Muscarinic agonist-induced non-granular and granular secretion of amylase in the parotid gland of the anaesthetized rat.
The muscarinic agonist bethanechol was infused intravenously, under alpha- and beta-adrenoceptor blockade, in anaesthetized rats at various dose levels (5-10, 20 and 40-50 microg kg(-1) min(-1)) over 30 min. The amount of saliva secreted from the parotid gland was dose dependent at 95, 202 and 737microl, respectively. The salivary amylase activity was approximately the same at the two lower doses (506 U and 448 U, respectively), while it was higher (1268 U) at the highest dose. In response to the highest dose, but not to the lower doses, the total parotid glandular amylase activity and the numerical density of parotid acinar secretory granules were lowered, by 25 % and 22 %, respectively. Thus, in the rat parotid gland, agonists such as bethanechol, which use Ca(2+) as a second messenger, may release proteins not only by non-granular mechanisms but also, and in contrast to the general belief, by granule exocytosis.
Ekström
J
J
Department of Pharmacology, Institute of Physiology and Pharmacology, Göteborg University, Box 431, SE 405 30 Göteborg, Sweden. jorgen.ekstrom@pharm.gu.se
D000681:Amylases / Q000378:metabolism*; D000758:Anesthesia; D000818:Animals; D018723:Bethanechol / Q000494:pharmacology*; D005260:Female; D018721:Muscarinic Agonists / Q000494:pharmacology*; D010306:Parotid Gland / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D022142:Secretory Vesicles / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism
D018721:Muscarinic Agonists; D018723:Bethanechol; D000681:Amylases